Exicure Signs Equity-Financing Deals With HiTron Systems

Dow Jones

2024-11-15

By Connor Hart

Exicure has inked two equity-financing deals, receiving $10 million in exchange for a controlling interest in the company.

The Chicago biotechnology company will receive $1.3 million from HiTron Systems, a South Korean security-systems provider, for 433,333 shares of its common stock. Upon the deal's closing, HiTron will have the right to appoint two nominees to the Exicure's board, subject to certain conditions, it said Thursday.

Separately, Exicure will sell an additional 2.9 million shares of its common stock to HiTron, also for $3 apiece, or $8.7 million. Upon closing of this subsequent investment, HiTron will have the right to appoint additional nominees in proportion to its equity interest.

Shares edged 1.3% lower, to $3.14, in after-hours trading.

The company, which previously received an extension to show compliance with all applicable listing criteria by Nov. 14, believes it will meet these requirements following its equity-financing deals.

Write to Connor Hart at connor.hart@wsj.com

(END) Dow Jones Newswires

November 14, 2024 18:13 ET (23:13 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2483354122"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2483354122\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2483354122?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-15 07:13","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2483354122","market":"fut","top_or_hot":-1,"title":"Exicure Signs Equity-Financing Deals With HiTron Systems","media":"Dow Jones","content":"<html><body><font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Connor Hart \n</p>\n<pre>\n \n</pre>\n<p>\n  Exicure has inked two equity-financing deals, receiving $10 million in exchange for a controlling interest in the company. \n</p>\n<p>\n  The Chicago biotechnology company will receive $1.3 million from HiTron Systems, a South Korean security-systems provider, for 433,333 shares of its common stock. Upon the deal's closing, HiTron will have the right to appoint two nominees to the Exicure's board, subject to certain conditions, it said Thursday. \n</p>\n<p>\n  Separately, Exicure will sell an additional 2.9 million shares of its common stock to HiTron, also for $3 apiece, or $8.7 million. Upon closing of this subsequent investment, HiTron will have the right to appoint additional nominees in proportion to its equity interest. \n</p>\n<p>\n  Shares edged 1.3% lower, to $3.14, in after-hours trading. \n</p>\n<p>\n  The company, which previously received an extension to show compliance with all applicable listing criteria by Nov. 14, believes it will meet these requirements following its equity-financing deals. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Connor Hart at connor.hart@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 14, 2024 18:13 ET (23:13 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones & Company, Inc.\n</p>\n</font></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>Exicure Signs Equity-Financing Deals With HiTron Systems</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nExicure Signs Equity-Financing Deals With HiTron Systems\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\">\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2024-11-15 07:13</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Connor Hart \n</p>\n<pre>\n \n</pre>\n<p>\n  Exicure has inked two equity-financing deals, receiving $10 million in exchange for a controlling interest in the company. \n</p>\n<p>\n  The Chicago biotechnology company will receive $1.3 million from HiTron Systems, a South Korean security-systems provider, for 433,333 shares of its common stock. Upon the deal's closing, HiTron will have the right to appoint two nominees to the Exicure's board, subject to certain conditions, it said Thursday. \n</p>\n<p>\n  Separately, Exicure will sell an additional 2.9 million shares of its common stock to HiTron, also for $3 apiece, or $8.7 million. Upon closing of this subsequent investment, HiTron will have the right to appoint additional nominees in proportion to its equity interest. \n</p>\n<p>\n  Shares edged 1.3% lower, to $3.14, in after-hours trading. \n</p>\n<p>\n  The company, which previously received an extension to show compliance with all applicable listing criteria by Nov. 14, believes it will meet these requirements following its equity-financing deals. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Connor Hart at connor.hart@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 14, 2024 18:13 ET (23:13 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones & Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4215","symbol_name":"住宅房地产投资信托","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2483354122","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2483354122","pubTimestamp":1731625980,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Exicure has inked two equity-financing deals, receiving $10 million in exchange for a controlling interest in the company.The Chicago biotechnology company will receive $1.3 million from HiTron Systems, a South Korean security-systems provider, for 433,333 shares of its common stock. Upon the deal's closing, HiTron will have the right to appoint two nominees to the Exicure's board, subject to certain conditions, it said Thursday.Separately, Exicure will sell an additional 2.9 million shares of its common stock to HiTron, also for $3 apiece, or $8.7 million. Upon closing of this subsequent investment, HiTron will have the right to appoint additional nominees in proportion to its equity interest.Shares edged 1.3% lower, to $3.14, in after-hours trading.The company, which previously received an extension to show compliance with all applicable listing criteria by Nov. 14, believes it will meet these requirements following its equity-financing deals.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4215":"住宅房地产投资信托","XCUR":"Exicure, Inc.","BK4585":"ETF&股票定投概念","BK4139":"生物科技","BK4588":"碎股","EQR":"资产住宅公司"},"translate_title":"Exicure与HiTron Systems签署股权融资协议","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EQR":1,"XCUR":0.9},"content_text":"By Connor Hart \n\n\n \n\n\n  Exicure has inked two equity-financing deals, receiving $10 million in exchange for a controlling interest in the company. \n\n\n  The Chicago biotechnology company will receive $1.3 million from HiTron Systems, a South Korean security-systems provider, for 433,333 shares of its common stock. Upon the deal's closing, HiTron will have the right to appoint two nominees to the Exicure's board, subject to certain conditions, it said Thursday. \n\n\n  Separately, Exicure will sell an additional 2.9 million shares of its common stock to HiTron, also for $3 apiece, or $8.7 million. Upon closing of this subsequent investment, HiTron will have the right to appoint additional nominees in proportion to its equity interest. \n\n\n  Shares edged 1.3% lower, to $3.14, in after-hours trading. \n\n\n  The company, which previously received an extension to show compliance with all applicable listing criteria by Nov. 14, believes it will meet these requirements following its equity-financing deals. \n\n\n \n\n\n  Write to Connor Hart at connor.hart@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 14, 2024 18:13 ET (23:13 GMT)\n\n\n  Copyright (c) 2024 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1}}}